73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Risk-taking behavior on roads in Victoria, Australia increased during lockdowns, study shows

Risk-taking behavior on roads in Victoria, Australia increased during lockdowns, study shows

by Monash UniversityCredit: Pixabay/CC0 Public DomainReduced travel on Victoria's roads during the COVID-19 pandemic did not equate to proportionate reductions in road trauma.New research&nbs

Risk-taking behavior on roads in Victoria, Australia increased during lockdowns, study shows

by Monash UniversityCredit: Pixabay/CC0 Public DomainReduced travel on Victoria's roads during the COVID-19 pandemic did not equate to proportionate reductions in road trauma.New research&nbs
Study: Palliative care provided at point of oncology surgery does not improve patient outcomes

Study: Palliative care provided at point of oncology surgery does not improve patient outcomes

by Vanderbilt University Medical CenterCredit: Unsplash/CC0 Public DomainOne of the most important advances in palliative care in oncology over the past 15 years has been the recognition that pal

Study: Palliative care provided at point of oncology surgery does not improve patient outcomes

by Vanderbilt University Medical CenterCredit: Unsplash/CC0 Public DomainOne of the most important advances in palliative care in oncology over the past 15 years has been the recognition that pal
Major progress in curing brain tumors by blocking certain functions in cells with a docked molecule

Major progress in curing brain tumors by blocking certain functions in cells with a docked molecule

by University of GothenburgThe researchers’ molecule Z4P inhibits one of the mechanisms that regulate protein production in a cancer cell. This inhibition causes the cancer cell to die. Three pic

Major progress in curing brain tumors by blocking certain functions in cells with a docked molecule

by University of GothenburgThe researchers’ molecule Z4P inhibits one of the mechanisms that regulate protein production in a cancer cell. This inhibition causes the cancer cell to die. Three pic
Researchers compare tumor characteristics, survival outcome of different bile duct cancers

Researchers compare tumor characteristics, survival outcome of different bile duct cancers

byBoston University School of MedicineCredit: CC0 Public DomainCholangiocarcinoma (CCA) or bile duct cancer, is a rare, aggressive liver cancer with a poor prognosis, which occurs mostly in peop

Researchers compare tumor characteristics, survival outcome of different bile duct cancers

byBoston University School of MedicineCredit: CC0 Public DomainCholangiocarcinoma (CCA) or bile duct cancer, is a rare, aggressive liver cancer with a poor prognosis, which occurs mostly in peop
Trial of cell-based therapy for high-risk lymphoma leads to FDA breakthrough designation

Trial of cell-based therapy for high-risk lymphoma leads to FDA breakthrough designation

by Krista Conger,Stanford UniversityScanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAIDCAR-T cell therapy, which

Trial of cell-based therapy for high-risk lymphoma leads to FDA breakthrough designation

by Krista Conger,Stanford UniversityScanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAIDCAR-T cell therapy, which
Study results show conjugate therapy produced remissions in one-third of patients with drug-resistant ovarian cancer

Study results show conjugate therapy produced remissions in one-third of patients with drug-resistant ovarian cancer

by Dana-Farber Cancer InstituteAntitumor activity of mirvetuximab soravtansine. (A) Maximum percentage change in target lesion size from baseline. Best response according to RECIST is indicated b

Study results show conjugate therapy produced remissions in one-third of patients with drug-resistant ovarian cancer

by Dana-Farber Cancer InstituteAntitumor activity of mirvetuximab soravtansine. (A) Maximum percentage change in target lesion size from baseline. Best response according to RECIST is indicated b
Using a seaweed sugar to trigger immune responses that suppress melanomas

Using a seaweed sugar to trigger immune responses that suppress melanomas

by H. Lee Moffitt Cancer Center & Research InstituteMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0Immunother

Using a seaweed sugar to trigger immune responses that suppress melanomas

by H. Lee Moffitt Cancer Center & Research InstituteMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0Immunother
Increased risk of prostate cancer in men with BRCA2 gene fault

Increased risk of prostate cancer in men with BRCA2 gene fault

by Cancer Research UKCredit: CC0 Public DomainMen with the BRCA2 gene fault have an increased risk of prostate cancer and could benefit from PSA (prostate specific antigen) testing to help detect

Increased risk of prostate cancer in men with BRCA2 gene fault

by Cancer Research UKCredit: CC0 Public DomainMen with the BRCA2 gene fault have an increased risk of prostate cancer and could benefit from PSA (prostate specific antigen) testing to help detect
Automated bone scan index prognostic for prostate cancer

Automated bone scan index prognostic for prostate cancer

(HealthDay)—The automated Bone Scan Index (aBSI) is an independent prognostic imaging biomarker of overall survival (OS) in metastatic castration-resistant prostate cancer (mCRPC), according to a stud

Automated bone scan index prognostic for prostate cancer

(HealthDay)—The automated Bone Scan Index (aBSI) is an independent prognostic imaging biomarker of overall survival (OS) in metastatic castration-resistant prostate cancer (mCRPC), according to a stud
Novobiocin attacks BRCA-mutated cancer cells from within and without, study shows

Novobiocin attacks BRCA-mutated cancer cells from within and without, study shows

byDana-Farber Cancer InstituteEfficacy of POLθ inhibition in HR-deficient cancers requires CD8+T cells.a,bK14-Cre-Brca1f/f;Trp53f/fTNBC tumors from syngeneic FVB/12

Novobiocin attacks BRCA-mutated cancer cells from within and without, study shows

byDana-Farber Cancer InstituteEfficacy of POLθ inhibition in HR-deficient cancers requires CD8+T cells.a,bK14-Cre-Brca1f/f;Trp53f/fTNBC tumors from syngeneic FVB/12
New thesis on prognostication for patients with myelodysplastic syndrome

New thesis on prognostication for patients with myelodysplastic syndrome

by Karolinska InstitutetCredit: Pixabay/CC0 Public DomainMaria Creignou from the Hematology Unit (HERM) at the Department of Medicine, Huddinge (MedH) is defending her thesis: "Improving pro

New thesis on prognostication for patients with myelodysplastic syndrome

by Karolinska InstitutetCredit: Pixabay/CC0 Public DomainMaria Creignou from the Hematology Unit (HERM) at the Department of Medicine, Huddinge (MedH) is defending her thesis: "Improving pro
Drug combination provides a one-two punch attack against colorectal cancer

Drug combination provides a one-two punch attack against colorectal cancer

by National Cancer InstituteOn the left,SN38, the active metabolite of irinotecan, traps TOP1 on DNA, forming TOP1 cleavage complexes that are degraded upon their formation, as seen by the

Drug combination provides a one-two punch attack against colorectal cancer

by National Cancer InstituteOn the left,SN38, the active metabolite of irinotecan, traps TOP1 on DNA, forming TOP1 cleavage complexes that are degraded upon their formation, as seen by the